Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 5/20 | 0.50 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | LDHA | P00338 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycolic Acid SCHEMBL4555780 | 0.91 | CA4 (0.50) | CA4OR51E2CASP1FFAR3HDAC3 | |
| Glycolic Acid SCHEMBL134226 | 0.91 | CA4 (0.50) | CA4OR51E2CASP1FFAR3HDAC3 | |
| Glycolic Acid SCHEMBL14661525 | 0.91 | CA4 (0.50) | CA4OR51E2CASP1FFAR3HDAC3 | |
| Glycolic Acid SCHEMBL4522823 | 0.91 | CA4 (0.50) | CA4OR51E2CASP1FFAR3HDAC3 | |
| Glycolic Acid SCHEMBL21297631 | 0.91 | CA4 (0.50) | CA4OR51E2CASP1FFAR3HDAC3 | |
| Glycolic Acid SCHEMBL26512 | 0.91 | CA4 (0.50) | CA4OR51E2CASP1FFAR3HDAC3 | |
| Glycolic Acid SCHEMBL991430 | 0.91 | — | — | |
| Glycolic Acid SCHEMBL1002389 | 0.91 | CA4 (0.50) | CA4OR51E2CASP1FFAR3HDAC3 | |
| Glycolic Acid SCHEMBL15441504 | 0.91 | CA4 (0.50) | CA4OR51E2CASP1FFAR3HDAC3 | |
| Glycolic Acid SCHEMBL331529 | 0.91 | CA4 (0.50) | CA4OR51E2CASP1FFAR3HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 458 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559453-B2 | Sulfonic acid-modified polyisocyanate and preparation method therefor | WANHUA CHEMICAL GROUP CO., LTD. (CN) | 2026-02-24 | — | — | US | claimed |
| EP-4144780-B1 | SULFONIC ACID-MODIFIED POLYISOCYANATE AND PREPARATION METHOD THEREFOR | WANHUA CHEMICAL GROUP CO LTD (CN) | 2025-12-24 | — | — | EP | claimed |
| CN-115466201-B | Sulfonic acid modified polyisocyanate and preparation method thereof | 万华化学集团股份有限公司 | 2024-05-03 | — | — | CN | claimed |
| US-20230257344-A1 | SULFONIC ACID-MODIFIED POLYISOCYANATE AND PREPARATION METHOD THEREFOR | WANHUA CHEMICAL GROUP CO., LTD. (CN) | 2023-08-17 | — | — | US | claimed |
| EP-4144780-A1 | SULFONIC ACID-MODIFIED POLYISOCYANATE AND PREPARATION METHOD THEREFOR | Wanhua Chemical Group Co., Ltd. (CN) | 2023-03-08 | — | — | EP | claimed |
| WO-2022257585-A1 | SULFONIC ACID-MODIFIED POLYISOCYANATE AND PREPARATION METHOD THEREFOR | 万华化学集团股份有限公司 | 2022-12-15 | — | — | WO | claimed |
| CN-115466201-A | Sulfonic acid modified polyisocyanate and preparation method thereof | 万华化学集团股份有限公司 | 2022-12-13 | — | — | CN | claimed |
| CN-112175011-B | Continuous preparation method of homogeneous organic molybdenum compound | 中国石油化工股份有限公司 | 2022-09-27 | — | — | CN | claimed |
| CN-112703055-A | Selective oxidation catalyst and oxidation of C in the presence of a selective oxidation catalyst2Process for the production of hydrocarbons | 沙特基础工业全球技术公司 | 2021-04-23 | — | — | CN | claimed |
| CN-112175011-A | Continuous preparation method of homogeneous organic molybdenum compound | 中国石油化工股份有限公司 | 2021-01-05 | — | — | CN | claimed |
| US-9896776-B2 | Chemical and electrochemical synthesis and deposition of chalcogenides from room temperature ionic liquids | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2018-02-20 | — | — | US | claimed |
| US-20160153108-A1 | CHEMICAL AND ELECTROCHEMICAL SYNTHESIS AND DEPOSITION OF CHALCOGENIDES FROM ROOM TEMPERATURE IONIC LIQUIDS | UNIV TEXAS (US) | 2016-06-02 | — | — | US | claimed |
| US-20150329751-A1 | REACTIVE COMPOSITION COMPRISING POLYAMINES AND A DISPERSION CONTAINING URETDIONE GROUPS | EVONIK INDUSTRIES AG (DE) | 2015-11-19 | — | — | US | claimed |
| US-20130112110-A1 | CHEMICAL AND ELECTROCHEMICAL SYNTHESIS AND DEPOSITION OF CHALCOGENIDES FROM ROOM TEMPERATURE IONIC LIQUIDS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2013-05-09 | — | — | US | claimed |
| US-20120129963-A1 | SYNTHESIS OF NOVEL MULTIFUNCTIONAL CARDANOL'S DERIVATIVES AND THEIR USE AS HALOGEN FREE POLYURETHANIC FOAMS PRECURSORS | CIMTEC LAB S.P.A. (IT) | 2012-05-24 | — | — | US | claimed |
| EP-2451762-A1 | SYNTHESIS OF NOVEL MULTIFUNCTIONAL CARDANOL'S DERIVATIVES AND THEIR USE AS HALOGEN FREE POLYURETHANIC FOAMS PRECURSORS | Cimteclab S.R.L. (IT) | 2012-05-16 | — | — | EP | claimed |
| US-5856420-A | MISCIBILITY | ARCO CHEMICAL TECHNOLOGY, L.P. (US) | 1999-01-05 | — | — | US | claimed |
| WO-1997039063-A1 | BIS(ISOBUTYRALDIMINE) OF 1,4-DIAMINOBUTANE IN HDI TRIMER AND BIURET-BASED COATINGS | ARCO CHEMICAL TECHNOLOGY, L.P. (US) | 1997-10-23 | — | — | WO | claimed |
| US-12637535-B2 | Non-ionic hydrophilized polyisocyanates having a very low monomer content | COVESTRO DEUTSCHLAND AG (DE) | 2026-05-26 | — | — | US | disclosed |
| US-3954900-A | POLYESTERURETHANES | CASSELLA FARBWERKE MAINKUR ATIENGESELLSCHAFT (DT) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230257344-A1 | SULFONIC ACID-MODIFIED POLYISOCYANATE AND PREPARATION METHOD THEREFOR | TST, SULT1A1, SULT2A1 | CA4 614/4885OR51E2 69/4885CASP1 3936/4885 |
| US-12559453-B2 | Sulfonic acid-modified polyisocyanate and preparation method therefor | TMT1A, SRMS, FTO | CA4 1304/4885OR51E2 521/4885CASP1 1448/4885 |
| US-20120129963-A1 | SYNTHESIS OF NOVEL MULTIFUNCTIONAL CARDANOL'S DERIVATIVES AND THEIR USE AS HALOGEN FREE POLYURETHANIC FOAMS PRECURSORS | EBP, CYP51A1, HSD17B7 | CA4 3172/4885OR51E2 1062/4885CASP1 443/4885 |
| US-12637535-B2 | Non-ionic hydrophilized polyisocyanates having a very low monomer content | NUDT1, UTS2R, PUF60 | CA4 1167/4885OR51E2 1364/4885CASP1 3568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.